Emoxipine® (Emoxipine)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceMethyl ethylpyridinolMethyl ethylpyridinol
Similar drugsTo uncover
  • Cardiocipine
    solution d / infusion 
    BIOSINTEZ, PAO     Russia
  • Cardiocipine
    solution w / m in / in 
    BIOSINTEZ, PAO     Russia
  • Methyl ethylpyridinol
    solution for injections 
    ATOLL, LLC     Russia
  • Methyl ethylpyridinol
    solution for injections 
    ELLARA, LTD.     Russia
  • Methyl ethylpyridinol
    solution for injections 
    Company DEKO, LLC     Russia
  • Methyl ethylpyridinol-Eskom
    solution for injections 
    ESKOM NPK, OAO     Russia
  • Emoticon Optics
    drops d / eye 
    SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products     Russia
  • Emoxibel
    solution d / infusion 
       
  • Emoxibel
    solution for injections 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Emoxibel
    drops d / eye 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Emoxibel
    solution w / m in / in 
    BELMEDPREPARATY, RUP     Republic of Belarus
  • Emoxipine®
    drops d / eye 
    MOSCOW ENDOCRINE FACTORY, FSUE     Russia
  • Emoxipine
    solution w / m in / in 
    MOSCOW ENDOCRINE FACTORY, FSUE     Russia
  • Emoxipine
    drops d / eye 
    FARMENT FIRM, LLC     Russia
  • Emoxipine
    solution for injections 
    MOSCOW ENDOCRINE FACTORY, FSUE     Russia
  • Emoxipine-AKOS
    drops d / eye 
    SYNTHESIS, JSC Joint-stock Kurgan Society of Medical Preparations and Products     Russia
  • Emoxipine-Acti
    solution d / infusion 
    Aktifarm, OOO     Russia
    • Dosage form: & nbspEye drops.
    Composition:1 ml of the solution contains:
    Active substance: methyl ethylpyridinol hydrochloride 10.0 mg
    Excipients: sodium sulfite anhydrous 2.5 mg, sodium benzoate 2.0 mg, potassium dihydrogen phosphate 5.4 mg, sodium hydrophosphate dodecahydrate 6.5 mg, methyl cellulose water soluble 6.5 mg, water for injection up to 1 ml.
    Description:Colorless or slightly colored, slightly opalescent liquid.
    Pharmacotherapeutic group:Antioxidant.
    ATX: & nbsp

    S.01.X.A   Other drugs for the treatment of eye diseases

    Pharmacodynamics:The drug reduces the permeability of capillaries, strengthens the vascular wall, stabilizes the cell membrane, inhibits platelet aggregation, reduces clotting and blood viscosity, has antiaggregation and antihypoxic effect.
    Pharmacokinetics:The drug quickly penetrates the tissues of the eye, where it is deposited and metabolized. In the tissues of the eye, the concentration is higher than in the blood. There were 5 metabolites, represented by dealkylated and conjugated products of its transformation. Metabolised in the liver: Metabolites are excreted by the kidneys. It binds to plasma proteins on average by 42%.
    Indications:- treatment and prevention of inflammation and burns of the cornea;
    - treatment of hemorrhages in the anterior chamber of the eye;
    - treatment and prevention of bleeding in the sclera in the elderly;
    - thrombosis of the central vein of the retina and its branches;
    - treatment of myopia complications;
    diabetic retinopathy.
    Contraindications:Individual hypersensitivity to the components of the drug, pregnancy, the period of breastfeeding, children under 18 years of age.
    Pregnancy and lactation:See section "Contraindications".
    Dosing and Administration:The drug is instilled in the conjunctival cavity 1-2 drops 2-3 times a day. The duration of the course of treatment depends on the course of the disease (usually 3-30 days) and is determined by the doctor. In the presence of indications and good tolerability of the drug, the course of treatment can be continued up to 6 months or repeated 2-3 times a year.
    INSTRUCTION FOR USE OF THE COVER-DRYER

    1. Remove the aluminum cap and rubber stopper from the bottle using scissors.
    2. Put on the vial a polyethylene lid-dropper, which is attached to the vial, after removing the package from it.
    3.Turn the bottle upside down and drip down the drops by pressing the dropper body.
    4. Close the cap-dropper with a small cap, tearing up three membranes at the bottom of the cap-dropper.
    Side effects:Perhaps a burning sensation, itching, short-term conjunctival hyperemia, rarely - local allergic reactions.
    Overdose:At present, cases of drug overdose (when instilled in a conjunctival sac) have not been reported.
    Interaction:The drug should not be mixed with other medicinal solutions.
    Special instructions:If it is necessary to simultaneously apply other eye drops, the drug is instilled last, after full absorption
    previous drug (not earlier than 15 minutes). When shaken, it forms a foam on the surface due to the presence of methylcellulose in the composition. Involuntary shaking can occur during transportation to occur during transport of the drug. Foaming does not affect the quality of the drug, foam disappears after a short time.
    Form release / dosage:Eye drops 1%.
    Packaging:5 ml into glass bottles.1 bottle with a lid-dropper and instruction on the use of the drug is placed in a pack of cardboard.
    Storage conditions:In the dark place at a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:2 years. Shelf life after the opening - 1month.
    Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LS-002151
    Date of registration:16.11.2011 / 03.12.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:MOSCOW ENDOCRINE FACTORY, FSUE MOSCOW ENDOCRINE FACTORY, FSUE Russia
    Manufacturer: & nbsp
    Information update date: & nbsp2016-08-27
    Illustrated instructions
    Instructions
    Up